Hutch News
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
August 26, 2019
Two early-career Fred Hutch scientists receive prestigious fellowships for prostate cancer research
Alexandra Corella wins Ford Foundation funding; Sander Frank earns NIH training fellowship
New study reveals weakness in emerging type of aggressive prostate tumor
Tumors that turn off androgen receptor may have turned on new drug target
The latest in prostate cancer research: 7 takeaways
7 takeaways from community symposium highlighting recent advances in prevention, screening and treatment
Dr. Yiting Lim named AACR NextGen Star
Charting the landscape of prostate cancer mutations: Postdoc to present work at annual American Association for Cancer Research meeting
Cancer prevention community mourns epidemiologist Dr. Alan Kristal
Pioneering researcher studied how diet can lower cancer risk
DNA methylation: a link between physical activity and reduced prostate cancer progression?
From the Dai, Stanford, and Wright Groups, Public Health Sciences Division
US cancer death rate has declined for at least 25 years
Fred Hutch experts weigh in on milestone report from American Cancer Society
Dr. Joachim Deeg named Miklos Kohary and Natalia Zimonyi Kohary Endowed Chair for Cancer Research
Endowment will support future research for myelodysplastic syndromes
An upgrade in prostate cancer prognosis predictions
From the Stanford Group, Public Health Sciences Division
Parsing the deadliness of prostate cancer
Fred Hutch researcher zeroes in on biomarkers to better predict aggressive form of the disease
Dr. James Dai receives $2.1M NCI grant for cancer biomarker research
Biostatistician plans to use funds to develop statistical models to further precision cancer prevention and treatment
Supper, sleep, circadian rhythms and cancer risk
Q&A: How going against our internal clock can trigger disease
Prostate cancer risk: Medicare claims are a powerful link
From the Unger Group, Public Health Sciences Division
What's new in prostate cancer: 5 takeaways
‘Many reasons for optimism’ says expert at annual community symposium
How do we bridge gaps in health equity?
Researchers and community members discuss outreach, relationship building at 2018 Pathways to Equity Symposium
Finasteride can reduce prostate cancer risk long term
Fred Hutch study taps big data to tease out extended cancer-prevention benefit of drug used for enlarged prostate, hair loss
New support for active surveillance of prostate cancer
From the Etzioni Group, Public Health Sciences Division
Could a prostate cancer drug save lives from radiation injury?
Early research shows potential for approved hormone-blocking drug to protect from deadly effects of nuclear blast
Prostate cancer and the power of PTEN
From the Stanford Group, Public Health Sciences Division
Overcoming androgen therapy resistance in prostate cancer
From the Peter Nelson Lab, Human Biology Division
'Movember' a reminder for dudes to go to the doctor
Growing facial hair in November part of spotlight on men’s health awareness — and the lack thereof
Targeted therapies push metastatic prostate cancer in new directions
Combination therapy could help stave off new “escape variant” of disease that arises in response to powerful treatments
Connecting the dots between weight loss and prostate cancer
U.S. veterans help shed light on link between dropping pounds and slowing progression of the disease
Removing barriers to precision treatment of metastatic prostate cancer
GENTleMEN study aims to help men with advanced disease access genetic testing and counseling